Russell Investments Group
RLYB icon

Russell Investments Group’s Rallybio RLYB Stock Holding History

Russell Investments Group’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-131
Closed -$1.23K – 3778
2024
Q3 		$1.23K Sell
131
-668
-84% -$6.43K ﹤0.01% 3459
2024
Q2 		$8.56K Buy
799
+293
+58% +$3.97K ﹤0.01% 3104
2024
Q1 		$7.48K Buy
+506
New +$7.05K ﹤0.01% 2887
2023
Q3 		– Sell
-34
Closed -$1.54K – 3610
2023
Q2 		$1.54K Buy
+34
New +$1.67K ﹤0.01% 3277

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Russell Investments Group's RLYB Position: Q4 2024 in Review

Russell Investments Group sold out of Rallybio (RLYB) in Q4 2024, closing a stake of 131 shares — an estimated $1.23K sold.

Russell Investments Group first reported a position in RLYB in Q2 2023 and held it in 4 quarters. The position peaked at $8.56K in Q2 2024. 49 funds tracked by Wall St. Rank hold RLYB as of Q4 2024.

  • Russell Investments Group reported no remaining Rallybio position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 131 Rallybio shares in Q4 2024, an estimated $1.23K.
  • Russell Investments Group first reported a position in Rallybio in Q2 2023 and held it in 4 quarters.
  • Russell Investments Group's Rallybio position peaked at $8.56K in Q2 2024.
  • 49 funds tracked by Wall St. Rank held Rallybio as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.